Biomedical Research

Clinical evidence, research, and medical intelligence in Biomedical Research.

University of Miami recruits tenure-track faculty in cell and systems biology

University of Miami Miller School of Medicine is recruiting tenure-track faculty in cell and systems biology across assistant to full professor ranks.

By Dr. A. Nikhil Krishnan, MBBS · Oct 26, 2026 · 5 min read

Biomedical Research·Nat Immunol

Scripps Research opens tenure-track assistant professor search

Scripps Research is recruiting a tenure-track assistant professor across multiple departments, with a Fall 2027 start and rolling…

Oct 21, 2026

Biomedical Research·Nat Immunol

Hasselt University opens molecular translational research professor post

Hasselt University is recruiting an associate professor or professor to build a molecular translational research program with major…

Oct 21, 2026

Biomedical Research·Nat Immunol

ShanghaiTech opens faculty posts in immunology, GPCRs and drug discovery

ShanghaiTech University is recruiting faculty for life science and biomedical research, with priority areas in immunology, GPCRs, and…

Oct 21, 2026

Biomedical Research·Nature

ShanghaiTech Opens Faculty Posts in Immunology, GPCRs and Drug Discovery

ShanghaiTech University is recruiting faculty for life science, immunology, GPCR biology and AI-driven drug discovery across its research…

Oct 20, 2026

Biomedical Research·STAT

David Sabatini jury verdict sets $6 million damages award

A jury ruled for ousted Cambridge scientist David Sabatini, setting a $6 million damages award in a dispute…

Oct 18, 2026

Biomedical Research·NIH

Stephanie Hicks, PhD, joins NIGMS in biomedical technology and structural biology

Stephanie Hicks, PhD, is a NIGMS program director overseeing biomedical technology development, research resources, and structural biology grants.

Oct 17, 2026

Biomedical Research

Clinical evidence, research, and medical intelligence in Biomedical Research.

In Brief The 5-minute rounds

New hypertension guideline lowers the treatment threshold to 130/80 mm Hg.
Phase 3 GLP-1 trial reports a 20% cut in major adverse cardiac events.
FDA clears a next-generation CAR-T therapy for relapsed lymphoma.
Meta-analysis links early mobilisation to shorter ICU length of stay.
Rapid guidance broadens empiric antibiotics for suspected sepsis.